Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill
Co-Diagnostics (CODX) announced its participation at BioUtah's Life Sciences Day on the Hill at the Utah State Capitol Rotunda on January 30, 2025. The event, presented by the Utah Life Sciences Innovation Caucus, the Utah Governor's Office of Economic Opportunity, and BioUtah, features over 25 Utah life sciences companies.
At the event, Co-Dx will showcase its upcoming Co-Dx PCR testing platform for at-home and point-of-care detection of infectious diseases, including COVID-19, influenza, RSV, HPV, and tuberculosis. The platform features cloud-based analysis capabilities for tracking disease outbreaks and is operated through a smartphone interface.
The company notes that the Co-Dx PCR platform, including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and associated tests and software, is currently under FDA review and not yet available for sale.
Co-Diagnostics (CODX) ha annunciato la sua partecipazione alla Giornata delle Scienze della Vita di BioUtah presso il Rotonda del Campidoglio dello Stato dell'Utah il 30 gennaio 2025. L'evento, presentato dal Caucus per l'Innovazione delle Scienze della Vita dell'Utah, dall'Ufficio del Governatore dell'Utah per le Opportunità Economiche e da BioUtah, coinvolgerà oltre 25 aziende delle scienze della vita dell'Utah.
Durante l'evento, Co-Dx presenterà la sua prossima piattaforma di test Co-Dx PCR per la rilevazione a domicilio e in punti di assistenza di malattie infettive, tra cui COVID-19, influenza, RSV, HPV e tubercolosi. La piattaforma offre capacità di analisi basate su cloud per monitorare i focolai di malattia ed è operata tramite un'interfaccia per smartphone.
L'azienda segnala che la piattaforma Co-Dx PCR, inclusi Co-Dx PCR Home™, Co-Dx PCR Pro™, l'app mobile e i test e software associati, è attualmente sotto revisione FDA e non è ancora disponibile per la vendita.
Co-Diagnostics (CODX) anunció su participación en el Día de Ciencias de la Vida de BioUtah en la Rotonda del Capitolio del Estado de Utah el 30 de enero de 2025. El evento, presentado por el Caucus de Innovación en Ciencias de la Vida de Utah, la Oficina del Gobernador de Utah para Oportunidades Económicas y BioUtah, contará con más de 25 empresas de ciencias de la vida de Utah.
En el evento, Co-Dx mostrará su próxima plataforma de pruebas Co-Dx PCR para la detección en casa y en el punto de atención de enfermedades infecciosas, incluyendo COVID-19, influenza, RSV, HPV y tuberculosis. La plataforma presenta capacidades de análisis basadas en la nube para rastrear brotes de enfermedades y se opera a través de una interfaz de teléfono inteligente.
La empresa señala que la plataforma Co-Dx PCR, incluyendo Co-Dx PCR Home™, Co-Dx PCR Pro™, la aplicación móvil y las pruebas y software asociados, está actualmente bajo revisión de la FDA y aún no está disponible para la venta.
Co-Diagnostics (CODX)는 2025년 1월 30일 유타 주 의사당 로턴다에서 열리는 BioUtah의 생명과학의 날 행사에 참여할 것이라고 발표했습니다. 유타 생명과학 혁신 모임, 유타 주지사 경제 기회 사무소 및 BioUtah가 주최하는 이번 행사에는 25개 이상의 유타 생명과학 회사가 참여합니다.
이번 행사에서 Co-Dx는 COVID-19, 인플루엔자, RSV, HPV 및 결핵을 포함한 감염병을 가정에서 및 즉각적인 검사를 위한 Co-Dx PCR 테스트 플랫폼을 선보일 예정입니다. 이 플랫폼은 질병 발생 추적을 위한 클라우드 기반 분석 기능을 제공하며 스마트폰 인터페이스를 통해 작동됩니다.
회사는 Co-Dx PCR 플랫폼, Co-Dx PCR Home™, Co-Dx PCR Pro™, 모바일 애플리케이션 및 관련 테스트와 소프트웨어가 현재 FDA 검토 중이며 판매를 위해 아직 출시되지 않았다고 전했습니다.
Co-Diagnostics (CODX) a annoncé sa participation à la Journée des Sciences de la Vie de BioUtah au Rotonde du Capitole de l'État de l'Utah le 30 janvier 2025. L'événement, présenté par le Caucus de l'Innovation en Sciences de la Vie de l'Utah, le Bureau du Gouverneur de l'Utah pour les Opportunités Économiques et BioUtah, mettra en avant plus de 25 entreprises des sciences de la vie de l'Utah.
Lors de l'événement, Co-Dx présentera sa prochaine plateforme de test Co-Dx PCR pour la détection à domicile et au point de soins des maladies infectieuses, y compris le COVID-19, la grippe, le RSV, le HPV et la tuberculose. La plateforme dispose de capacités d'analyse basées sur le cloud pour suivre les épidémies et fonctionne via une interface smartphone.
L'entreprise note que la plateforme Co-Dx PCR, y compris Co-Dx PCR Home™, Co-Dx PCR Pro™, l'application mobile ainsi que les tests et logiciels associés, est actuellement en cours d'examen par la FDA et n'est pas encore disponible à la vente.
Co-Diagnostics (CODX) gab bekannt, dass es am 30. Januar 2025 an dem Life Sciences Day von BioUtah im Rotunda des Utah State Capitol teilnehmen wird. Die Veranstaltung, die vom Utah Life Sciences Innovation Caucus, dem Büro des Gouverneurs von Utah für wirtschaftliche Möglichkeiten und BioUtah präsentiert wird, umfasst über 25 Unternehmen im Bereich der Lebenswissenschaften in Utah.
Auf der Veranstaltung wird Co-Dx seine kommende Co-Dx PCR-Testplattform für die Heim- und punktuelle Erkennung von Infektionskrankheiten, einschließlich COVID-19, Influenza, RSV, HPV und Tuberkulose, vorstellen. Die Plattform bietet cloudbasierte Analysefunktionen zur Verfolgung von Krankheitsausbrüchen und wird über eine Smartphone-Oberfläche gesteuert.
Das Unternehmen weist darauf hin, dass die Co-Dx PCR-Plattform, einschließlich der Co-Dx PCR Home™, Co-Dx PCR Pro™, der mobilen App und der zugehörigen Tests und Software, derzeit von der FDA überprüft wird und noch nicht zum Verkauf erhältlich ist.
- None.
- None.
The Life Sciences Day on the Hill is presented by the Utah Life Sciences Innovation Caucus, the
The event follows the Company's participation with the
This year's event takes place today, January 30, from 11:00 AM to 2:00 PM MST, and is expected to feature exhibits from over 25 Utah life sciences companies. Co-Dx's booth will showcase the Company's upcoming at-home and point-of care Co-Dx PCR testing platform* for detection of infectious diseases, including COVID-19, influenza, RSV, HPV and tuberculosis. The platform also incorporates cloud-based analysis to help build situational awareness and provide support to track infectious disease outbreaks at the community and regional level, all operated via an intuitive smartphone interface.
*The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is not available for sale. The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.
About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a
View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-exhibit-at-bioutahs-2025-life-sciences-day-on-the-hill-302364228.html
SOURCE Co-Diagnostics
FAQ
What products will Co-Diagnostics (CODX) showcase at BioUtah's 2025 Life Sciences Day?
What is the regulatory status of CODX's new PCR testing platform?
When and where is BioUtah's 2025 Life Sciences Day taking place?
What diseases can CODX's new PCR platform detect?
